Search Results

Diflorasone 200 mg  | 99.02%

TargetMol

Diflorasone is a synthetic glucocorticoid with anti-inflammatory and immunosuppressive properties. Like other glucocorticoids, diflorasone enters the cell by diffusion across the cell membrane and binds to the glucocorticoid receptor (GR) in the cytoplasm. The receptor complex subsequently translocates to the nucleus and activates or represses genes by interacting with short, palindromic DNA sequences called glucocorticoid […]

More Information Supplier Page

Alcaftadine 200 mg  | Purity Not Available

TargetMol

Alcaftadine is an H1 histamine receptor antagonist indicated for the prevention of itching associated with allergic conjunctivitis.

More Information Supplier Page

Alcaftadine 25 mg  | Purity Not Available

TargetMol

Alcaftadine is an H1 histamine receptor antagonist indicated for the prevention of itching associated with allergic conjunctivitis.

More Information Supplier Page

Ropinirole hydrochloride 200 mg  | 99.95%

TargetMol

Ropinirole a selective dopamine D2 receptors agonist (Ki: 29 nM). Ropinirole Hydrochloride is the hydrochloride salt form of ropinirole, a non-ergot dopamine agonist with antiparkinsonian property.

More Information Supplier Page

Thymopentin 2 mg  | Purity Not Available

TargetMol

Synthetic pentapeptide corresponding to the amino acids 32-36 of thymopoietin and exhibiting the full biological activity of the natural hormone. THYMOPENTIN is an immunomodulator which has been studied for possible use in the treatment of rheumatoid arthritis, AIDS, and other primary immunodeficiencies.

More Information Supplier Page

PIK-75 100 mg  | 98.19%

TargetMol

PIK-75, a DNA-PK and PI3K inhibitor, suppresses DNA-PK(IC50=2 nM), p110α(IC50=5.8 nM) and p110γ(IC50=76 nM).

More Information Supplier Page

Fruquintinib 25 mg  | Purity Not Available

TargetMol

Fruquintinib is an orally available, small molecule inhibitor of vascular endothelial growth factor receptors (VEGFRs), with potential anti-angiogenic and antineoplastic activities.

More Information Supplier Page

Fruquintinib 2 mg  | Purity Not Available

TargetMol

Fruquintinib is an orally available, small molecule inhibitor of vascular endothelial growth factor receptors (VEGFRs), with potential anti-angiogenic and antineoplastic activities.

More Information Supplier Page